-The Hindu Business Line India is being too accommodating of MNCs The Centre is needlessly apologetic about our IPR laws. It set up an IPR ‘think tank’ in October 2014, perhaps responding to a view that our IPRs are not strong enough to invite foreign investment. Last January, Prime Minister Modi and President Obama issued a joint statement which “committed to establish an annual high-level Intellectual Property Working Group”. In November, Modi...
More »SEARCH RESULT
Pharma companies team up to clean industry’s image
-The Times of India MUMBAI: For the first time ever, some of India's biggest pharmaceutical companies, cutting across their respective associations and representing nearly half the Rs 93,000 crore market, have come together to push for ethical marketing practices to clean up the industry's image. The forum, comprising of 40 to 50 domestic and MNC firms, had its first closed-door meeting on October 14. It has made a "voluntary and moral commitment"...
More »India, Brazil cross swords with US at WTO -Sriram Lakshman
-The Hindu Moratorium on Intellectual Property Complaints Switzerland and the U.S. have begun a campaign at the World Trade Organisation (WTO) to not renew a moratorium on ‘non-violation complaints and situations’ for intellectual property rights that expires at the end of the year. Intellectual property laws are governed internationally by the Trade-Related Intellectual Property Rights (TRIPS) Agreement. The moratorium first came into being in 1995, when the WTO was born. And has survived...
More »Pharma Patents after 10 Years
-Economic and Political Weekly Ten years on, the progressive provisions of the amended Indian Patents Act are being watered down. Ten years have passed since the Indian Patents Act, 1970 was amended in 2005 to bring the country’s laws in line with the Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS). The most important of the 2005 amendments was the introduction of product patents for 20 years, including for pharmaceutical products,...
More »Govt may negotiate price of drugs before market entry -Sushmi Dey
-The Times of India NEW DELHI: The government may negotiate prices of patented medicines with their manufacturers before allowing pharmaceutical companies to launch them in India. The move, a first of its kind, is also likely to be applied on patented drugs that are already being sold in the country, an official source said. An inter-ministerial committee, evaluating the mechanism to negotiate prices of patented medicines, has recently sought detailed information about...
More »